KKR & Co (KKR) Receives a Hold from Morgan Stanley
In a report released today, Michael Cyprys from Morgan Stanley maintained a Hold rating on KKR & Co (KKR – Research Report), with a price ...
Integrating diverse asset classes is the new ‘cornerstone’ of investing – KKR
Discover how public and private markets are converging to create new opportunities for credit investments, with a focus on Asia-Pacific high-yield debt.
Evercore ISI Reaffirms Their Buy Rating on KKR & Co (KKR)
Evercore ISI analyst Glenn Schorr maintained a Buy rating on KKR & Co (KKR – Research Report) yesterday and set a price target of $165.00.
PE Hub6h
KKR invests in software company XOi
In connection to this deal, XOi has acquired Specifx, a San Francisco-based on-demand data enrichment and metadata retrieval platform for field service equipment.
Zacks.com on MSN4h
Why KKR & Co. Inc. (KKR) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...
Private Equity Is Booming. Does It Live Up to the Hype?
Boost your returns and diversify your portfolio by investing in private markets. But does it live up to the hype? It can, if ...
Business Times13h
Bain is said to near 500 billion yen deal for Mitsubishi pharma unit
BAIN Capital is nearing a deal to buy Mitsubishi Chemical Group’s pharmaceutical unit, sources familiar with the matter said, ...
alternativeswatch22h
Canyon Partners adds capital formation talent
Canyon Partners recently added Georg Machinist and Matt Brody as managing directors in its U.S. capital formation team.
Moneyweb12h
Bain is said to near $3bn deal for Mitsubishi pharma unit
The US-based private equity firm and Mitsubishi are finalising details of a transaction that could be announced as soon as ...